Effects of bulbus allii macrostemi on clinical outcomes and oxidized low-density lipoprotein and plasminogen in unstable angina/non-ST-segment elevation myocardial infarction patients

Phytotherapy Research

Volumn 22, Issue 11, 2008, Pages 1539-1543

  Liu, Yan ^a   Zhang, Lei ^a   Liu, Yun Fang ^a   Yan, Fang Fang ^a   Zhao, Yu Xia ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Bulbus allii macrostemi; Drug therapy; Unstable angina non ST segment elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BULBUS ALLII MACROSTEMI EXTRACT; ENOXAPARIN; ISOSORBIDE 5 NITRATE; METOPROLOL; OXIDIZED LOW DENSITY LIPOPROTEIN; PLANT EXTRACT; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BULBUS ALLII MACROSTEMI; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; ELECTROCARDIOGRAM; FEMALE; HEADACHE; HEART INFARCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; NAUSEA; NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; VOMITING;

AGED; ANGINA, UNSTABLE; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; MYOCARDIAL INFARCTION; ONIONS; PHYTOTHERAPY; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TREATMENT OUTCOME;

ANGINA; BULBUS;

EID: 57349088755     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2534     Document Type: Article

References (25)

1. Adams M, Kinlay S, Blake G, Orford J, Ganz P, Selwyn A. 2000. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes. Annul Rev Med 51: 149-167.
2. Braunwald E. 1998. Unstable angina: an etiologic approach to management [editorial]. Circulation 98: 2219-2222.
3. Cai GX, Li YM, Zheng B, Peng SZ. 2007. Preliminary assessment of dose-response relationship and safety of ultramicro herbal powders prepared for decoction. Chin J New Drugs 16: 682-684
4. Cheng XJ, Wang NL, Wu B, Wang MW, Yao XS. 2000. The selected effective prescription of Gualou-xiebai-baijiu-tang on myocardial anoxia and ischemia in rodents. J Shenyang Pharm Univ 17: 375-377.
5. Davies MJ. 2000. The pathophysiology of acute coronary syndromes. Heart 83: 361-366.
6. Ding F, Jiao SP, Fang L. 2005. The research of Bulbus Allii Macrostemi extracts reducing the -OH and anti DNA injury. J Chin Med Mater 28: 592-593.
7. Eugene B, Elliott MA, John WB et al. 2002. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: Summary Article: a report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 106: 1893-1900.
8. Gao XM. 2002. Chinese Pharmacy, 1st edn. Traditional Chinese Medicine Press: Beijing.
9. Hamm CW, Bertrand M, Braunwald E. 2001. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 358: 1533-1538.
10. Han L. 2002. New Practical Technique of Chinese Drugs Preparation, 1st edn. Chemical Industry Press: Beijing.
11. He X, Qiu F, Shoyama Y, Tanaka H, Yao X. 2002. Two new steroidal saponins from 'Gualou-xiebai-baijiu-tang' consisting of Fructus trichosanthis and Bulbus allii macrostemi. Chem Pharm Bull (Tokyo) 50: 653-655.
12. James JO, David JW, David EN. 2005. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vase Biol 25: 2470-2479.
13. Jawahar LM, Dayuan L. 2002. Identification, regulation and function of a novel lectin-like oxidized low-density. J Am Coll Cardiol 39: 1429-1435.
14. Jeffrey LA, Cynthia DA, Elliott MA et al. 2007. ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation 116: e148-e304.
15. Li XH, Gu LZ, Zhang BS, Wang AH, Duan SJ. 1994. The effects of Bulbus Allii Macrostemi extracts on antioxidation. J Chin Med Mater 17: 34-37.
16. Libby P. 2001. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104: 365-372.
17. 45Ca. Appl Radiat lsot 63: 151-155.
18. Miles LA, Hawley SB, Baik N, Andronicos NM, Castellino FJ, Parmer RJ. 2005. Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front Biosci 10: 1754-1762.
19. Paul ES, Chao HW, Richard DW, John R, Almeida TJ, Anderson SV. 2003. New markers of inflammation and endothelial cell activation: part I. Circulation 108: 1917-1923.
20. Schafer AI. 2003. Genetic and acquired determinants of individual variability of response to antiplatelet drugs. Circulation 108: 910-911.
21. Selwyn AP. 2003. Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol 91. 3H-11H.
22. Wang M, Lamers RJ, Korthout HA et al. 2005. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother Res. 19: 173-182.
23. Xie H, Xu HQ, Li H. 2004. The effect on mice clotting time and antithrombotic activity of Allium macrostemon Bunge extractions. Lishizhen Med Mater Med Res 15: 811-812.
24. Yang YM. 2006. The application of supermicro-pulverization technology of Chinese drugs. China Pharm 15: 58-59.
25. Zhang Q, Gao E. 2003. Advances in the study of Allium Macrostemon Bunge. Zhongguo Guo Zhong Yao Za Zhi 28: 105-107.